Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile
Cancer Research, Statistics and Treatment

@crstonline

Peer-reviewed open-access journal for research & info on cancer. Web: CRSTonline.com; Email: [email protected]; Facebook: @CRSTonline

ID: 1118465129262108673

linkhttp://CRSTonline.com calendar_today17-04-2019 10:44:01

380 Tweet

1,1K Followers

171 Following

Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

Dr. Jha and team identify a rare EGFR exon 18 mutation in lung adenocarcinoma using targeted next-generation sequencing. Read the molecular tumor board article here: bit.ly/3NQMIV9 #CRST #moleculartumorboard #genetics #EGFR #lungcancer #cancer #medtwitter

Dr. Jha and team identify a rare EGFR exon 18 mutation in lung adenocarcinoma using targeted next-generation sequencing. Read the molecular tumor board article here: bit.ly/3NQMIV9 #CRST #moleculartumorboard #genetics #EGFR #lungcancer #cancer #medtwitter
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

Head-and-neck cancers account for 30-40% of all cancer cases in India. Dr. Prabhash et al. present an update to Indian clinical guidelines for the management of HNSCC. Read here: bit.ly/3UkTTZZ #headandneckcancer #CRST #CancerTreatment #Cancers #MedTwitter #HNSCC

Head-and-neck cancers account for 30-40% of all cancer cases in India. Dr. Prabhash et al. present an update to Indian clinical guidelines for the management of HNSCC. Read here: bit.ly/3UkTTZZ
#headandneckcancer #CRST #CancerTreatment #Cancers #MedTwitter #HNSCC
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

Our new issue is live! Looking forward to your comments and criticism. Sincere thanks to all authors, reviewers, editors and publishers for your contribution. Read here: bit.ly/3Kf29px Vanita Noronha, MBBS MD DM Tata Memorial Hospital #CRST #oncology #CancerResearch #MedTwitter

Our new issue is live! Looking forward to your comments and criticism. Sincere thanks to all authors, reviewers, editors and publishers for your contribution. 
Read here: bit.ly/3Kf29px
<a href="/VanitaNoronha/">Vanita Noronha, MBBS MD DM</a> <a href="/TataMemorial/">Tata Memorial Hospital</a> #CRST #oncology #CancerResearch #MedTwitter
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

Dr. Malik and team present a clinico-epidemiologic study of head-and-neck cancer patients from Haryana, India. The male-to-female ratio was 8.6:1 with a high incidence of oropharyngeal cancer. Read on: bit.ly #CRST #cancer #oncologia #MedTwitter #CancerResearch

Dr. Malik and team present a clinico-epidemiologic study of head-and-neck cancer patients from Haryana, India. The male-to-female ratio was 8.6:1 with a high incidence of oropharyngeal cancer. Read on: bit.ly
#CRST #cancer #oncologia #MedTwitter #CancerResearch
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

Dr. Krishnatry and team study the translation and validation of the Hindi, Marathi, and Bangla versions of the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire: Anal Cancer (QLQ-ANL27) module. Read here: bit.ly/3TWepzw

Dr. Krishnatry and team study the translation and validation of the Hindi, Marathi, and Bangla versions of the European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire: Anal Cancer (QLQ-ANL27) module. Read here: bit.ly/3TWepzw
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

Dr Singh and team assess the 8-year long-term superiority of gefitinib over chemotherapy in terms of overall and progression-free survival (PFS), objective response rate (ORR), and safety. Read here: bit.ly/4azKlis #CRST #oncology #MedTwitter #cancer #CancerResearch

Dr Singh and team assess the 8-year long-term superiority of gefitinib over chemotherapy in terms of overall and progression-free survival (PFS), objective response rate (ORR), and safety. Read here: bit.ly/4azKlis #CRST #oncology #MedTwitter #cancer #CancerResearch
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

Indian patients with NSCLC have 29% EGFR positivity, 8.1% ALK positivity, and 3.5% ROS1 positivity, when tested with RT-PCR, IHC, and FISH. Read the molecular profile by Dr Munde and team here: bit.ly/3TVVjYS #CRST #ALK #ROS1 #EGFR #CancerResearch #MedTwitter

Indian patients with NSCLC have 29% EGFR positivity, 8.1% ALK positivity, and 3.5% ROS1 positivity, when tested with RT-PCR, IHC, and FISH. Read the molecular profile by Dr Munde and team here: bit.ly/3TVVjYS #CRST #ALK #ROS1 #EGFR #CancerResearch #MedTwitter
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

Dr. Poolakkil and team present a study on varying clinical presentations and patterns of recurrence of colorectal cancer. What is the incidence of second primary colorectal cancer and what are the salvage rates? Read here to find out: bit.ly/4aAZrVs #CRST

Dr. Poolakkil and team present a study on varying clinical presentations and patterns of recurrence of colorectal cancer. What is the incidence of second primary colorectal cancer and what are the salvage rates? Read here to find out: bit.ly/4aAZrVs #CRST
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

Dr. Neha Singh and team present an audit of liver metastatic tumors, highlighting adenocarcinomas often originating from the pancreaticobiliary tract, as predominant. Read here: bit.ly/3VJwWPk #CRST #MedTwitter #LiverMetastasis #Oncology #CancerResearch

Dr. Neha Singh and team present an audit of liver metastatic tumors, highlighting adenocarcinomas often originating from the pancreaticobiliary tract, as predominant. Read here: bit.ly/3VJwWPk #CRST #MedTwitter #LiverMetastasis #Oncology #CancerResearch
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

New study by Dr. Nanda Kumar et al. explores CD44's role in Oral Squamous Cell Carcinoma (OSCC) progression and treatment resistance. Discover insights on cancer stem cells and therapeutic strategies:bit.ly/4eMFc9F #CRST #MedTwitter #Cancer #OralCancerResearch #CD44

New study by Dr. Nanda Kumar et al. explores CD44's role in Oral Squamous Cell Carcinoma (OSCC) progression and treatment resistance. Discover insights on cancer stem cells and therapeutic strategies:bit.ly/4eMFc9F 
#CRST #MedTwitter #Cancer #OralCancerResearch #CD44
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

A study by Sonia et al. on nursing students' knowledge of breast cancer and self-examination highlights the critical need for comprehensive breast health education in nursing curricula. Read here: bit.ly/3XqTars #CRST #CancerResearch #BreastCancer #Nursing #MedTwitter

A study by Sonia et al. on nursing students' knowledge of breast cancer and self-examination highlights the critical need for comprehensive breast health education in nursing curricula. Read here: bit.ly/3XqTars
#CRST #CancerResearch #BreastCancer #Nursing #MedTwitter
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

A study by Jimmy et al. showed the 7-probe FISH panel is highly effective for diagnosing and managing multiple myeloma in resource-limited settings. Read more: bit.ly/3yO5icA #CRST #MultipleMyeloma #CancerResearch #MedicalDiagnostics #MedTwitter

A study by Jimmy et al. showed the 7-probe FISH panel is highly effective for diagnosing and managing multiple myeloma in resource-limited settings. Read more: bit.ly/3yO5icA
#CRST #MultipleMyeloma #CancerResearch #MedicalDiagnostics #MedTwitter
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

Dr. Roy and team present an audit of head-and-neck cancer trials in India, highlighting significant transparency and ethics issues. Of 356 trials, 63% lacked clear endpoints, and only 2.2–8% were published. Read more: bit.ly/4g9UaYm #CRST #CancerResearch #ClinicalTrials

Dr. Roy and team present an audit of head-and-neck cancer trials in India, highlighting significant transparency and ethics issues. Of 356 trials, 63% lacked clear endpoints, and only 2.2–8% were published. Read more: bit.ly/4g9UaYm #CRST #CancerResearch #ClinicalTrials
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

Dr. Sunilkumar and team present a 10-year audit of cancer cases at Malabar Cancer Center in Kerala, highlighting lung cancer as the most common among men and breast cancer among women. Read more: bit.ly/4dIQevX #CRST #MedTwitter #CancerResearch #Oncology #BreastCancer

Dr. Sunilkumar and team present a 10-year audit of cancer cases at Malabar Cancer Center in Kerala, highlighting lung cancer as the most common among men and breast cancer among women. Read more: bit.ly/4dIQevX #CRST #MedTwitter #CancerResearch #Oncology #BreastCancer
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

A study on metastatic colorectal cancer in South Asia uncovers crucial genomic insights: 78.6% of patients had actionable variants, with high mutation rates in APC, TP53, and KRAS. Read more: bit.ly/4cMavzp #CRST #CancerResearch #ColorectalCancer #CancerGenomics

A study on metastatic colorectal cancer in South Asia uncovers crucial genomic insights: 78.6% of patients had actionable variants, with high mutation rates in APC, TP53, and KRAS. Read more: bit.ly/4cMavzp #CRST #CancerResearch #ColorectalCancer #CancerGenomics
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

Dr. Singh and team found ChatGPT useful for manuscript structure but noted it frequently provides inaccurate and fictional information. Read more: bit.ly/3z3cvWa #CRST #ChatGPT #HematologyOncology #CancerResearch #ScientificWriting #MedTwitter

Dr. Singh and team found ChatGPT useful for manuscript structure but noted it frequently provides inaccurate and fictional information. Read more: bit.ly/3z3cvWa #CRST #ChatGPT #HematologyOncology #CancerResearch #ScientificWriting #MedTwitter
Cancer Research, Statistics and Treatment (@crstonline) 's Twitter Profile Photo

Dr. Aggarwal and team highlight NLP's potential to revolutionize oral cancer diagnosis and treatment, while also addressing critical challenges in data standardization and privacy. Learn more: bit.ly/3MwIwZC #CRST #OralCancer #NLP #CancerResearch

Dr. Aggarwal and team highlight NLP's potential to revolutionize oral cancer diagnosis and treatment, while also addressing critical challenges in data standardization and privacy. Learn more: bit.ly/3MwIwZC #CRST #OralCancer #NLP #CancerResearch